comprehensive
Previous article:
Medicare details structure of new drug price negotiation program
Next article: New documents shed light on MD Anderson Cancer Institute feud
Next article: New documents shed light on MD Anderson Cancer Institute feud
explore
focus
-
Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc
2025-10-01 23:35 -
NIH study of ME/CFS points to clear biological hallmarks
2025-10-01 23:35 -
New documents shed light on MD Anderson Cancer Institute feud
2025-10-01 23:29 -
Anthos stroke drug appears safer than common blood thinner
2025-10-01 22:47 -
World's first CRISPR
2025-10-01 22:42 -
New documents shed light on MD Anderson Cancer Institute feud
2025-10-01 22:16